Tolremo raises €2.4M Seed round
18 September 2017· Basel, Switzerland· health, biotech, drug_discovery, oncology, small_molecule_therapeutics, epigenetics, b2b
To advance the company's discovery and development of breakthrough medicines to target drug resistance in cancer therapy.
About Tolremo
Stage
Series A
Headquarters
Basel, Switzerland
Founded
2017
Team Size
6–20
Sectors
healthbiotechdrug_discoveryoncologysmall_molecule_therapeuticsepigeneticsb2b
Source: https://www.tolremo.com/news/tolremo-raises-chf-2-4-million-in-seed-financing/